Hyterra Ltd. has released a press release.
Clinical Trials and cash position
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from HyTerra
- Commitments Test Entity - Fourth Quarter Report
- Commitments Test Entity - Second Quarter Report
- BrainZ extends distribution agreement with GE Healthcare
- CE Mark recd for seizure detection s/ware&Quarterly C/Flow
- Continues quarterly sales growth
Later from HyTerra
- New funding for clinical trial using BrainZ technology
- BrainZ launches latest model infant brain monitor in Europe
- BrainZ BRM3 infant brain monitor receives US FDA clearance
- Revenues from new BRM3 monitor expected in December quarter
- Pilot Study shows Better Seizure Management using RecogniZe
Follow HyTerra into a list and get an email when it puts out news.
Follow HyTerra